Rising Cancer Prevalence Creates Strong Demand for Immuno Oncology Drugs Worldwide
Rising clinical research activities and pharmaceutical investments are accelerating the development of next-generation immunotherapy drugs. Companies are focusing on improving treatment effectiveness and expanding therapeutic applications.
Market Overview
The Immuno-Oncology Drugs Market size was valued at US$ 77.80 billion in 2024 and is expected to reach US$ 237.73 billion by 2031....